Tag Archives: SGI

Spexis Announces Closing Of Capital Commitment Of Usd 4.5 Million From Sprim Global Investments (sgi) To Enable Initiation Of Colifin® Phase 3 Study

BIOTECH

Spexis announces closing of capital commitment of USD 4.5 million from SPRIM Global Investments (SGI) to enable initiation of ColiFin® Phase 3 study
April 18, 2023

Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today...

Read more
This site uses cookies to offer you a better browsing experience. By browsing this website, you agree to our use of cookies.
Accept